Researchers at The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have identified specific blood-based genomic biomarkers that distinguish inflammatory breast cancer from other subtypes, ...
May 6, 2026
0
4
Researchers at The University of Texas MD Anderson Cancer Center have identified a targetable driver of brain metastases in patients with aggressive inflammatory breast cancer. The study uncovers a novel role for soluble ...
Jan 29, 2026
0
9
University of Hawaiʻi Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms of breast cancer. The ...
Apr 18, 2024
0
39
A team of researchers affiliated with a host of medical institutions across the U.S. has found that the HDAC6 score can be used to predict the response of some types of cancer to administration of the histone ricolinostat.
